(Q48263890)

10 February 2018

title

Time-dependent effects of levodopa on regional brain dopamine metabolism and lipid peroxidation (English)

1 reference

10 February 2018

1 reference

2

LeWitt PA

1 reference

10 February 2018

Paul L. Juneau

3

object named as

Juneau PL

1 reference

10 February 2018

author name string

Loeffler DA

1

1 reference

10 February 2018

Camp DM

4

1 reference

10 February 2018

Arnold LA

5

1 reference

10 February 2018

Hyland K

6

1 reference

10 February 2018

publication date

1 December 1998

1 reference

10 February 2018

published in

Brain Research Bulletin

1 reference

10 February 2018

volume

47

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

663-667

1 reference

10 February 2018

L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Free radicals and the pathobiology of brain dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Quantitative autoradiographic localization of central dopamine D-1 and D-2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Clues to the mechanism underlying dopamine cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Dopamine formation from L-dopa administered exogenously is independent of dopaminergic neuronal activity: studies with in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Ontogeny of dopamine D1 receptors in rat forebrain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Effects of L-dopa on efflux of cerebral monoamines from synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

A radical hypothesis for neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Activities of 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan decarboxylases in rat brain: assay characteristics and distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Distinct monoamine oxidase A and B populations in primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2898%2900140-3

7 January 2021

10.1016/S0361-9230(98)00140-3

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018